Wildflower Ventures
Bridging Science and Sales in Agricultural Biologicals
Selling biologicals requires a different playbook.
If you’re here, something feels off.
Your biological product isn’t scaling.
Sales is frustrated.
R&D feels misunderstood.
Regulatory keeps introducing surprises.
You have yield data but no clear story.
Leadership thinks the solution is ‘hire better salespeople.’
This is a systems problem.
Most biological companies are using a chemistry playbook to sell biology. And it doesn’t work.
Ag-biological products do not behave like traditional chemistry. Their performance varies across crops, soils, and geographies, yet many companies try to launch them everywhere at once.
Without focus and alignment between product, claims, and sales strategy, even promising technologies struggle to gain real traction.
I am a scientific-commercial translator.
With 15 years in microbial product development in multinational corporations to startups, I’ve launched biological products across crop and livestock systems.
I help companies:
Align R&D, regulatory, and commercial teams
Translate complex science into sales-ready language
Design product development with commercialization in mind
Train sales teams to confidently sell differentiated products
Identify and fix the “short leg” in your product strategy
Narrow go-to-market strategy for real traction
My work sits at the intersection of science and sales.
Because that’s where biological products either succeed or stall.
The Three Pillars Framework
Most companies overinvest in one pillar and neglect the others.
I use a structured framework called the Three Pillars of Product Development to uncover which pillar is shorter than the others, because if any one pillar is weak, the product wobbles.
This framework was born from 15 years of industry experience where I implemented this framework myself. It’s how I designed my product development projects. By making sure that every task, experiment, or demo checks at least 2 of three pillars (ideally 3 of 3), you ensure that every dollar you spend bringing a product to market is working for you 3-fold.
What This Looks Like in Practice.
Here’s what often happens:
a product shows promising yield in a few locations
the field trial program is expanded the next year
Regulatory comes in and puts constraints on product registration and messaging.
R&D passes the finished product to commercial and tells them to go sell
No time for a launch plan
sales struggle to sell and defaults to yield and ROI conversations
revenue either never takes off or stagnates by year 3
Instead we do this:
Define the grower pain point that the product tackles
Narrow to one crop, one region, one management system
Align regulatory as early as possible and design the science around constraints
build the science story while the product is being researched and developed
train sales to answer hard questions confidently
develop a launch strategy that grows through time and not all at once
If your biological revenue is flat…
If your internal tension is rising…
If launch timelines keep stretching…
If your runway is running out…
I want to work with you.
Small to mid-sized biological companies.
Chemistry companies building biological portfolios.
Directors of Sales struggling with biological adoption.
R&D leaders preparing for launch.
Teams relaunching underperforming products.
Results You can Expect
When the science-to-sales is in alignment, you can expect:
Sales confidence increases.
Messaging sharpens and hits home.
Regulatory stops being a hurdle and starts being an asset.
Data becomes usable and accessible.
Launches are focused.
Conversion improves.
Products dominate niches instead of diluting within crowded markets.
Biology is complex. Selling doesn’t have to be.
Hi, I’m Whitney.
I’ve spent 15 years developing microbial and bio-based products for agriculture from greenhouse to field to commercialization.
I founded Wildflower Ventures to help ag biological companies bring products to life and make sure they grow.
My background spans:
Soil microbiome systems
Rumen microbiome systems
Multinational corporations
Startup environments
Product development and applied research
Commercial bridge-building
I’ve seen products succeed, and I’ve seen them stall. The difference is rarely the microbe.
Ready to strengthen your product’s foundation?
Let’s identify the short pillar - and fix it.